Discontinued — last reported Q3 '25
Impairment Charges
West Pharmaceutical Services Impairment Charges decreased by 95.9% to $300.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $300.00K to $300.00K. Over 4 years (FY 2021 to FY 2025), Impairment Charges shows an upward trend with a 20.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase signals potential operational issues, poor past investment decisions, or adverse market conditions for specific business units.
Detailed definition
These are non-cash charges recorded when the carrying value of an asset exceeds its fair market value. They indicate tha...
Peer comparison
Often seen during restructuring or economic downturns across industrial sectors.
impairment_charges_cfHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.40M | $1.40M | $1.40M | $0.00 | $200.00K | $1.40M | $4.60M | $1.90M | $1.50M | $3.50M | $2.70M | $600.00K | $300.00K | $1.00M | $5.40M | $300.00K | $3.80M | $300.00K | $7.30M | $300.00K |
| QoQ Change | — | +0.0% | +0.0% | -100.0% | — | +600.0% | +228.6% | -58.7% | -21.1% | +133.3% | -22.9% | -77.8% | -50.0% | +233.3% | +440.0% | -94.4% | >999% | -92.1% | >999% | -95.9% |
| YoY Change | — | — | — | — | -85.7% | +0.0% | +228.6% | — | +650.0% | +150.0% | -41.3% | -68.4% | -80.0% | -71.4% | +100.0% | -50.0% | >999% | -70.0% | +35.2% | +0.0% |
Business Segments
| Segment | Q1 '23 |
|---|---|
| Proprietary Products | $9.40M |
| Total | $1.90M |
Proprietary Products was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
Impairment Charges at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's impairment charges?
- West Pharmaceutical Services (WST) reported impairment charges of $300.00K in Q1 2026.
- How has West Pharmaceutical Services's impairment charges changed year-over-year?
- West Pharmaceutical Services's impairment charges decreased by 0.0% year-over-year, from $300.00K to $300.00K.
- What is the long-term trend for West Pharmaceutical Services's impairment charges?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's impairment charges has grown at a 20.2% compound annual growth rate (CAGR), from $5.60M to $11.70M.
- What does impairment charges mean?
- A write-down of an asset's value because it is worth less than what is recorded on the balance sheet.